Status:
COMPLETED
Effects of Oligofructose and Barley on Satiety and Energy Intake
Lead Sponsor:
Unilever R&D
Conditions:
Appetite Regulation
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The effect of beta-glucan or fructo-oligosaccharide or their combination in bars on satiety and food intake was tested by supplying these bars on two consecutive days.
Detailed Description
Background: Increasing gastro-intestinal viscosity or colonic fermentation is suggested to help improve appetite control and reduce food intake. Beta-glucan (BG) and fructo-oligosaccharide (FOS) are f...
Eligibility Criteria
Inclusion
- Age at start of the study 18 till 60 years
- Quetelet-Index (BMI) from 21 till 32 kg/m2 inclusive
- Apparently healthy: measured by questionnaire: no reported current or previous metabolic diseases or chronic gastrointestinal disorders
- Reported dietary habits: no medically prescribed diet, no slimming diet, used to eat 3 meals a day, no vegetarian, macro-biotic or biologic dynamic food habits
- No Fibre supplements (only once a day)
- No blood donations during the study.
- Reported intense sporting activities less than 10h/w
- Reported alcohol consumption less than 21 units/w (female volunteers) or less than 28 units/w (male volunteers)
- Having a General Practitioner
- Informed consent signed
- Recruitment form filled out
Exclusion
- Smoking
- Dislike, allergy/intolerance or not known with the foods of the ad libitum meal
- Possible eating disorder (measured by SCOFF questionnaire)
- High or very high restrained eaters (measured by questionnaire) (men with BMI \< 27: restraint score \> 2.37, men with BMI less than 27: restraint score \> 3.04, women with BMI \< 26: restraint score \> 3.24, women with BMI less than 26: restraint score \> 3.41)
- Reported medical treatment that may affect eating habits/satiety
- Reported intolerance or allergy to test products
- Women reported lactating (or lactating \< 6 weeks ago), pregnant (or pregnant \< 3 months ago) or wish to become pregnant during the study
- Reported weight loss/gain (10%) in the last six month before the trial
- Reported participation in another biomedical trial 1 month before the start of the study
- Reported working on late turns -
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2007
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00776256
Start Date
February 1 2007
End Date
April 1 2007
Last Update
October 21 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unilever R&D Vlaardingen
Vlaardingen, Netherlands, 3133AT